AAAAAA

   
Results: 1-7 |
Results: 7
Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma
Authors: Lumry, W Noveck, R Weinstein, S Barnhart, F Vandermeer, A Murray, A Reisner, C
Citation: W. Lumry et al., Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma, ANN ALLER A, 86(3), 2001, pp. 297-303
A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler
Authors: Bensch, G Lapidus, RJ Levine, BE Lumry, W Yegen, U Kiselev, P Della Cioppa, G
Citation: G. Bensch et al., A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler, ANN ALLER A, 86(1), 2001, pp. 19-27
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
Authors: Nayak, AS Banov, C Corren, J Feinstein, BK Floreani, A Friedman, BF Goldsobel, A Gottschlich, GM Hannaway, PJ Lampl, KL Lapidus, RJ Lawrence, M Lumry, W Munk, Z Pearlman, D Scardella, AT Schenkel, EJ Segal, AT Segall, N Silverman, B Shneyer, L Nolop, KB Harrison, JE
Citation: As. Nayak et al., Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma, ANN ALLER A, 84(4), 2000, pp. 417-424
Combined salmeterol 50 mu g and fluticasone propionate 250 mu g in the Diskus device for the treatment of asthma.
Authors: Shapiro, G Lumry, W Wolfe, J Given, J White, MV Woodring, A Baitinger, L House, K Prillaman, B Shah, T
Citation: G. Shapiro et al., Combined salmeterol 50 mu g and fluticasone propionate 250 mu g in the Diskus device for the treatment of asthma., AM J R CRIT, 161(2), 2000, pp. 527-534
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler
Authors: Bernstein, DI Berkowitz, RB Chervinsky, P Dvorin, DJ Finn, A Gross, GN Karetzky, M Kemp, JP Laforce, C Lumry, W Mendelson, LM Nelson, H Pearlman, D Rachelefsky, G Ratner, P Repsher, L Segal, AT Selner, JC Settipane, GA Wanderer, A Cuss, FM Nolop, KB Harrison, JE
Citation: Di. Bernstein et al., Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler, RESP MED, 93(9), 1999, pp. 603-612
Tri-nasal triamcinolone acetonide nasal spray 200 and 400 mu g qd versus placebo and nasacort triamcinolone acetonide nasal aerosol 440 mu g qd in patients suffering from seasonal allergic rhinitis during the grass season
Authors: Rosenthal, R Berger, W Bronsky, E Dockhorn, R Korenblat, P Lampl, K Lumry, W Pollard, S Raphael, G Rohr, C Shapiro, G Valentine, M Wanderer, A Fleming, L LaVallee, N Stepanians, M Karafilidis, J Shilstone, J Ellis, E
Citation: R. Rosenthal et al., Tri-nasal triamcinolone acetonide nasal spray 200 and 400 mu g qd versus placebo and nasacort triamcinolone acetonide nasal aerosol 440 mu g qd in patients suffering from seasonal allergic rhinitis during the grass season, AM J RHINOL, 12(6), 1998, pp. 427-433
Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; A randomized, double-blind, active-controlled trial
Authors: Finn, AF Aaronson, D Korenblat, P Lumry, W Settipane, G Spector, S Woehler, T Drda, K Wood, CC
Citation: Af. Finn et al., Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; A randomized, double-blind, active-controlled trial, AM J RHINOL, 12(6), 1998, pp. 441-449
Risultati: 1-7 |